IO Biotech, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q3 2020 to Q3 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
IO Biotech, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q3 2020 to Q3 2024.
- IO Biotech, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$24M, a 10.8% decline year-over-year.
- IO Biotech, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$90.4M, a 13% decline year-over-year.
- IO Biotech, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$86.1M, a 20.5% decline from 2022.
- IO Biotech, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$71.5M, a 5.27% decline from 2021.
- IO Biotech, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$67.9M, a 464% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)